Related Experiment Videos
Inflammatory breast carcinoma: pathological or clinical entity?
R S Amparo1, C D Angel, L H Ana
1lnstituto Valenciano de Oncologiá, Valencia, Spain.
Breast Cancer Research and Treatment
|February 24, 2001
Summary
Clinically diagnosed inflammatory breast carcinoma (CIC) patients have poorer prognoses than those with occult inflammatory carcinoma (OIC). Differentiating these conditions is crucial for accurate therapeutic reporting and patient outcomes.
Area of Science:
- Oncology
- Pathology
Background:
- Inflammatory breast carcinoma (IBC) diagnosis typically relies on clinical symptoms, but pathologic findings like subdermal lymphatics involvement are not always present.
- The diagnostic sufficiency of pathologic findings alone for IBC, without clinical symptoms, remains debated.
Purpose of the Study:
- To compare clinical and pathological characteristics and outcomes of clinically diagnosed IBC (CIC) versus occult inflammatory carcinoma (OIC).
- To determine if CIC, with or without dermal lymphatics invasion, has a different prognosis than OIC.
Main Methods:
- Retrospective analysis comparing 163 CIC patients with 99 OIC patients.
- Analysis included age, menopausal status, nodal involvement, symptom duration, grade, hormone receptor status, metastasis, recurrence, disease-free survival (DFS), and overall survival (OS).
Main Results:
- CIC patients were younger, had shorter symptom duration, and more frequent visceral and brain metastases.
- Negative estrogen receptors were more common in CIC.
- Five-year DFS and OS were significantly shorter for CIC patients compared to OIC patients.
Conclusions:
- Clinically diagnosed IBC (CIC) has a poorer prognosis than occult inflammatory carcinoma (OIC).
- Clear differentiation between CIC and OIC is essential for accurate therapeutic reporting and improved patient management.